380 related articles for article (PubMed ID: 16343268)
41. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
[TBL] [Abstract][Full Text] [Related]
42. Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.
Olesen LH; Aggerholm A; Andersen BL; Nyvold CG; Guldberg P; Nørgaard JM; Hokland P
Br J Haematol; 2005 Nov; 131(4):457-67. PubMed ID: 16281935
[TBL] [Abstract][Full Text] [Related]
43. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.
Brakensiek K; Länger F; Kreipe H; Lehmann U
Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816
[TBL] [Abstract][Full Text] [Related]
44. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
Mori N; Yoshinaga K; Tomita K; Ohwashi M; Kondoh T; Shimura H; Wang YH; Shiseki M; Okada M; Motoji T
Leuk Res; 2011 Apr; 35(4):516-21. PubMed ID: 20828818
[TBL] [Abstract][Full Text] [Related]
45. Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia.
Cechova H; Lassuthova P; Novakova L; Belickova M; Stemberkova R; Jencik J; Stankova M; Hrabakova P; Pegova K; Zizkova H; Cermak J
Neoplasma; 2012; 59(2):168-74. PubMed ID: 22248274
[TBL] [Abstract][Full Text] [Related]
46. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.
Rethmeier A; Aggerholm A; Olesen LH; Juhl-Christensen C; Nyvold CG; Guldberg P; Hokland P
Br J Haematol; 2006 May; 133(3):276-83. PubMed ID: 16643429
[TBL] [Abstract][Full Text] [Related]
47. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Tiranova SA; Kakaĭ MP; Martynenko LS; Dziavgo LA
Ter Arkh; 2005; 77(7):22-7. PubMed ID: 16116904
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
[TBL] [Abstract][Full Text] [Related]
49. Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome.
Cheng YY; Chau D; Chan T; Gill H; Liang R; Kwong YL; Tse E
J Clin Pathol; 2010 Nov; 63(11):1008-11. PubMed ID: 20924036
[TBL] [Abstract][Full Text] [Related]
50. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
[TBL] [Abstract][Full Text] [Related]
51. DNA hypermethylation in breast cancer and its association with clinicopathological features.
Li S; Rong M; Iacopetta B
Cancer Lett; 2006 Jun; 237(2):272-80. PubMed ID: 16029926
[TBL] [Abstract][Full Text] [Related]
52. Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia.
Ekmekci CG; Gutiérrez MI; Siraj AK; Ozbek U; Bhatia K
Am J Hematol; 2004 Nov; 77(3):233-40. PubMed ID: 15495254
[TBL] [Abstract][Full Text] [Related]
53. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
[TBL] [Abstract][Full Text] [Related]
55. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
56. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
57. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.
Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
[TBL] [Abstract][Full Text] [Related]
58. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Nevill TJ; Shepherd JD; Sutherland HJ; Abou Mourad YR; Lavoie JC; Barnett MJ; Nantel SH; Toze CL; Hogge DE; Forrest DL; Song KW; Power MM; Nitta JY; Dai Y; Smith CA
Biol Blood Marrow Transplant; 2009 Feb; 15(2):205-13. PubMed ID: 19167680
[TBL] [Abstract][Full Text] [Related]
59. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
[TBL] [Abstract][Full Text] [Related]
60. Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.
Destro A; Ceresoli GL; Baryshnikova E; Garassino I; Zucali PA; De Vincenzo F; Bianchi P; Morenghi E; Testori A; Alloisio M; Santoro A; Roncalli M
Lung Cancer; 2008 Mar; 59(3):369-76. PubMed ID: 17920725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
